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Abstract 
 
As humans age, exposure to oxidative stress may induce protein degradation or aggregation; 
both resulting in loss of protein function. Protein oxidative damage remains a dominant 
pathology in many common ailments. To combat these pathologies, scientists must understand 
the nature of oxidative modifications and their effects on protein structure and dynamics. This 
work employs a range of mass spectrometry (MS) methods to characterize and analyze the 
effects of oxidative damage on the model protein myoglobin (Mb). Mb was oxidized using 
tert-butyl hydroperoxide, and the resulting modifications were characterized by top-down and 
bottom-up MS workflows. Hydrogen/deuterium exchange MS indicated elevated structural 
dynamics in oxidatively modified regions. Collision-induced activation showed that oxidized 
Mb loses heme more readily than its unmodified counterpart. Ion mobility experiments 
uncovered that collision-induced unfolding produces more compact non-native gas phase 
structures for the oxidized protein. The methods applied provide an analytical foundation for 
the comprehensive characterization of oxidative damage that will be applicable to many other 
proteins. 
Keywords 
Protein oxidation, Protein Dynamics, Mass Spectrometry, Reactive Oxygen Species, 
Myoglobin, Hydrogen Deuterium Exchange 
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Summary for Lay Audience 
Oxidative damage is the result of an overabundance of reactive oxygen-containing chemicals 
in the body. These chemicals arise as the result normal cellular processes but can be 
exacerbated by external factors like smoking or tanning. Antioxidants in the body combat the 
effects of these chemicals, but an imbalance can result in damaging reactions occurring inside 
of the body (i.e., oxidative damage). As living things age, deterioration of biological processes 
can be partially attributed to accumulation of oxidatively modified proteins – the biological 
building block for cells and tissues. Oxidative damage has been implicated as one of the causes 
of common ailments including glaucoma and neurodegenerative disorders such as Parkinson’s 
and Alzheimer’s disease. Looking into the eyes of someone who suffers glaucoma, the direct 
result of oxidative protein damage can be seen. The cloudiness in the eye is produced by the 
accumulation of proteins that have lost function due to extensive oxidation, unrepairable by 
the body. 
This work aims to examine the factors that lead to the disfunction of proteins after oxidative 
damage. Working with oxidized proteins poses difficulty because they tend to cause problems 
for many conventional analytical methods; one of these difficulties is their non-uniform mass 
distribution. Here, we developed a procedure that mimics the effects of reactive oxygen species 
in the body. Mass spectrometry (MS), a method involving the characterization of gaseous 
protein ions produced by electrospray ionization, proved to be a versatile approach that allowed 
us to accurately assess modifications. By applying various MS methods, we were able to 
determine the chemical nature of modifications, their locations, and their effects on protein 
structure and dynamics. In this way it was possible to obtain valuable information that might 
one day help with the development of treatments to combat oxidative damage. Earlier MS 
studies have produced valuable information on oxidized proteins but neglected certain methods 
due to onerous data analysis. The current work addresses many of these difficulties, thereby 
establishing a comprehensive MS-based platform for the characterization of oxidatively 
damaged proteins.   
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Chapter 1 - Introduction 
1.1 Proteins 
Proteins are among the key building block of all living organisms. Within the cell, proteins 
are responsible for a variety of roles encompassing signaling, catalysis, host defense, and 
transport.1,2 Given their diverse functions, fascination with proteins continuously grows, 
spanning multiple fields of study that range from basic physical chemistry to clinical 
research. Protein misfunction is linked to numerous diseases, creating an urgent need to 
better understand the fundamentals of protein structure and dyamics.3–11 
1.1.1 Structure 
Proteins are assembled by translation of mRNA at a ribosome, resulting in the creation of 
a polymeric chain of L-amino acids. Amino acids are composed of three main components: 
an amine group, a carboxylic acid group and a chiral -carbon bearing a sidechain (“R” 
group). When any two of the 20 possible amino acids bind together, they produce a peptide 
bond through the formation of an amide between the carboxylic acid group of one amino 
acid and amine group of the next (Figure 1). These peptide bonds exhibit partial double 
bond character, forcing the adjacent six atoms into a plane. 
 
Figure 1: Amide bond formation between two amino acids. 
The primary structure (amino acid sequence) serves as a unique identifier of each protein; 
this sequence dictates the protein folding behavior and therefore determines the final 
protein structure (Figure 2A). The conformational freedom of polypeptide chains arises 
primarily from rotation of the dihedral angles  and  on either side of -carbons.12 As the 
backbone arranges itself during the folding process, numerous intramolecular hydrogen 
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bonds form between backbone NH and CO groups. These hydrogen bonds give rise to two 
particularly favorable secondary structures; -helices and -sheets (Figure 2B).13,14  
Protein tertiary structures are further stabilized by disulfide bonds, hydrophobic contacts, 
salt bridges, and van der Waals contacts (Figure 2C).15,16 Natively folded proteins can also 
incorporate organic or inorganic moieties to introduce new functionality. Cofactors, such 
as heme, allow many proteins (e.g., hemoglobin, cytochrome c and myoglobin) to perform 
functions that go beyond features mediated by amino acid side chains. Quaternary structure 
refers to the oligomerization of two or more polypeptide chains into higher order 
complexes (Figure 2D). These subunits assemble through intermolecular contacts, forming 
complexes with diverse functions.17 Scientists have developed computer programs in an 
attempt to predict protein tertiary and quaternary structures (as well as protein function) on 
the basis of amino acid sequences. However, such sequence-based prediction algorithms 
are still at a relatively early stage of development.18,19   
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Figure 2: Different levels of protein structure. A) Primary structure: the sequence of amino 
acids building a protein (PDB:6F3V). B) Secondary structure: hydrogen bonds create ordered 
structures in terms of -helices (red - PDB:1COS) and -pleated sheets (orange – PDB:1ICL). 
C) Tertiary structure: intramolecular side chain interactions produce a folded protein 
(PDB:1WLA). D) Quaternary structure: the assembly of multiple amino acid chains and 
subunits (indicated by different colour) into a larger structure (PDB:1A3N). 
A) 
D) C) 
B) 
R-P-P-G-F-S-P-F-R 
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1.1.2 Protein Dynamics 
Seminal studies by scientists such as Kendrew, Ramachandran and Pauling uncovered the 
fundamentals of protein structure. However, even the availability of high-resolution X-ray 
structures does not necessarily reveal the biological functions of proteins.12,14,20 This is 
because protein function is usually not mediated by static structural features (such as those 
seen in X-ray crystallography). Instead,  the key to understanding protein function lies in 
protein dynamics, i.e., structural fluctuations that take place on multiple time scales, from 
picoseconds to seconds.1,17 Unravelling how protein conformers dynamically interact with 
the surrounding solvent, substrates, and other proteins is essential for understanding 
biological systems. 
The dynamics of a protein can be visualized as an amalgamation of kinetics and 
thermodynamics, where the protein continuously moves through its various Boltzmann-
allowed conformations on the free energy landscape. Conformations with low free energy 
values are thermodynamically preferred, but higher energy states are populated as well 
with certain probabilities that scale as exp(-G/RT), where G is the free energy difference 
relative to the ground state.21,22 Interactions with ligands can affect the conformational free 
energy, thereby either stabilizing or destabilizing various forms. 
In enzymes, structural motifs fold into specific catalytically active sites. Dynamic 
conformational motions are essential for enzyme-substrate interactions such that active 
sites can adopt conformations that are required for catalysis.23,24 The binding of substrates 
often produces “induced fit” conformational changes that allow catalytic events to take 
place.25,26 Motor proteins exemplify the relationship between dynamics and function 
particularly well, as they convert one form of energy into another. For example, F0F1 ATP 
Synthase harnesses a proton-motive force to drive the movement of a central rotor, thereby 
generating ATP.27–30  
Another example is hemoglobin, where the initial binding of O2 to a heme-cofactor induces 
a conformational change, as outlined by the Perutz mechanism.31–34 Binding of the first O2 
to the heme iron of the completely deoxygenated (T-state) protein induces a conformational 
change in the heme porphyrin plane. This event is transmitted via the distal histidine and 
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propagates through the entire protein, thereby cooperatively enhancing the favorability of 
O2 binding at the remaining three subunits. Eventually, these events produce the fully 
oxygenated R-state.35 The binding of effectors can trigger allosteric effects far away from 
the effector binding site. For example, effector binding can induce conformational changes 
that open or close binding regions elsewhere in the protein, providing the foundation of 
various biological regulation effects such as enzyme activation or deactivation.31,36–39 
Allosteric interactions are also important for various drug action mechanisms.40,41 
Considering how dependent protein function is on conformational dynamics, any factor 
that alters the structure and dynamics of the native state will likely be detrimental to normal 
function. Oxidative modifications are of paramount importance in this context, as outlined 
in the following section. 
1.1.3 Protein Oxidative Damage 
Protein oxidative damage represents an intriguing physiological phenomenon. Oxidative 
stress arises from an imbalance of reactive oxygen species (ROS) relative to antioxidant 
defense mechanisms within the body. These imbalances lead to biomolecular damage that 
adversely affects cellular functions.42–45 ROS include H2O2, and ROOH, but also free 
radicals such as O2
•-, •OH, and RO•. These species can arise from both endogenous and 
exogenous effects.46 Endogenously, ROS are generated during processes such as cellular 
respiration, NADPH oxidase oxidation, and peroxidation.46–50 Exogenous factors such as 
smoking and excessive radiation (e.g., tanning, X-rays) also contribute to ROS 
generation.46–49 ROS serve important physiological roles. In immune defense, neutrophils 
and eosinophils utilize myeloperoxidase and eosinophil peroxidase, respectively, to 
produce ROS for combating pathogens.47,51 ROS also serve a role during reversible 
oxidation of cysteine and methionine in cell signaling.46,52–55  
ROS have been implicated as one of the causes of common ailments including 
neurodegenerative disorders such as Parkinson’s and Alzheimer’s disease, and 
glaucomatous neurodegeneration.3,49,56–59 As organisms age, deterioration of biological 
processes can be partially attributed to accumulation of oxidatively damaged proteisn.4,58,60 
The body defends itself against ROS by diverting glucose 6-phosphate (G6P) from 
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glycolysis into a side reaction - the pentose monophosphate shunt.50 Here, NADPH is 
utilized for the reduction of hydrogen peroxide to water by glutathione (GSH) and catalase 
in different reactions. GSH and superoxide dismutase (SOD) both scavenge free radicals, 
while catalase breaks down H2O2.
44,53,55,61 
High concentrations of ROS induce oxidation of lipids and nucleic acids; however, proteins 
are the main subject of oxidative damage due to their high abundance,62 often leading to 
biomolecular damage that is detrimental to function.42–45 In proteins, ROS mainly target 
amino acid side chains (Figure 3), although the backbone is also somewhat susceptible to 
modification, in particular by •OH.5,60,63 All these modifications can lead to protein 
destabilization, aggregation and loss of function.3,5,49,64  
 
Figure 3: Common oxidative side chain oxidations and their associated mass shifts. 
Because of the many deleterious effects of ROS, a large focus has been put on identifying 
therapeutically effective antioxidants. Resveratrol (3,5,4’-trihydroxy-trans-stilbene), found 
in the skin of grapes, has promising effects in prolonging life expectancy through 
modulation of antioxidant metabolism enzymes and scavenging of free radicals.65–69  
Protein oxidation alters the physicochemical properties of amino acid side chains such as 
mass, charge, shape, and hydrophobicity. These changes, in turn, affect functional 
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properties including enzymatic activity and drug binding.1-6,70,62 If an intermediate or 
unfolded species becomes oxidized, it may lose its ability to refold to the native state due 
to altered intramolecular interactions. As well, natively folded proteins may unfold as a 
result of oxidative modifications. Both of these scenarios would most likely result in loss 
of function.71–73 If the protein is not subjected to proteasomal degradation and subsequently 
replaced, successive oxidation events will lead to the accumulation and/or aggregation of 
non-functional protein (Figure 4). For proteins that are not regenerated in the body (i.e., 
crystallin in the eye lens), the effects of ROS are accentuated. Crystallins become resistant 
to proteasomal degradation as a result of aging-related oxidative modification and will 
accumulate in the eye (cataract formation).71,74,75 Without the ability to repair or regenerate 
these proteins, oxidation causes permanent loss of function.74,76 
 
Figure 4: Both native and unfolded proteins may be subjected to oxidative damage when 
exposed to ROS. Upon slight oxidation, the protein may maintain its structure but will most 
likely be subjected to proteolysis. If oxidation products accumulate, the protein may lose 
the ability to exist in a folding equilibrium. The highly oxidized protein loses function and 
may become immune to proteolysis, aggregating inside the cell. 
1.1.4 Myoglobin 
Myoglobin represents a commonly used model system for experimental studies on protein 
structure and dynamics.21,77–85 It has a mass of 17.5 kDa and is composed of 8 -helices 
(Figure 5).86 In its native state, myoglobin exists as heme-bound holo-myoglobin (hMb) – 
granting it function as an oxygen reservoir in muscle tissue. The heme cofactor is contained 
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within a hydrophobic pocket where it forms multiple noncovalent linkages, along with a 
coordination bond of the iron center to the proximal His93.82 Due to the weak nature of the 
heme-protein interactions, myoglobin may also exist in its heme-free apo form (aMb). 
Heme loss causes the F helix to partially unfold while leaving the remaining structure 
relatively similar to native hMb.77,78,87 In physiologically active hMb the heme is in the 
Fe2+ state, but after prolonged oxygen exposure, iron will oxidize to Fe3+. The formation 
of metmyoglobin (Fe3+ hMb) is responsible for the brownish-red colour seen in aging red 
meat and is unable to bind O2.
88,89,90 Increased myoglobin concentration in urine serves as 
an indicator of muscle injury and renal failure, while the presence of protein-oxidized 
myoglobin in myocardial tissue has been identified to be indicative of acute myocardial 
infarction.91–93 
 
Figure 5: X-ray crystal structure of myoglobin from horse heart (PDB 1WLA). 
1.2 Classical Methods for Protein Structural Analysis  
1.2.1 UV-Vis Spectroscopy 
Ultraviolet visible (UV-Vis) absorption spectroscopy uses electromagnetic radiation with 
wavelengths in the range of 200 to 700 nm. This method is widely employed for 
quantitative assays involving organic, inorganic and biological analytes.94 
The Beer-Lambert law (Equation 1.1) establishes the relationship between absorbance (A) 
and concentration (c) of a chromophore for a certain path length (l). The molar absorption 
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coefficient   is specific to the sample being measured. In Equation 1.1, I0 denotes the 
incident light intensity, while I is the intensity of transmitted light.95 
𝐴 = 𝑙𝑜𝑔
𝐼0
𝐼
=  𝜀𝑙𝑐 
Equation 1.1 
UV-Vis spectroscopy is useful for determining protein concentrations by measuring the 
absorbance at 280 nm, where the aromatic residues tryptophan, phenylalanine and tyrosine 
absorb, or around 407 nm (Soret region) which is the peak absorbance of heme and related 
porphyrins.96,97 UV-Vis spectroscopy provides little direct information about protein 
structure, however, absorbance changes of cofactors such as heme can report on 
conformational changes. 
1.2.2 Circular Dichroism (CD) Spectroscopy 
CD spectroscopy exploits the differential absorption of left and right-circularly polarized 
light by chiral chromophores.98,99 This difference (molar ellipticity) is what constitutes a 
CD spectrum. CD spectroscopy is a valuable tool for the analysis of secondary structure. 
The absorbance in the far-UV range (180-250 nm) arises from peptide bonds and has 
characteristic CD signatures depending on the type of secondary structure (Figure 6).100–
102 In addition, CD in the near-UV range (260-320 nm) caused by absorption by aromatic 
amino acids and S-S bonds, is related to their respective environments and reveals tertiary 
structural information.98 CD signals can also be associated with cofactors such as heme in 
myoglobin or cytochrome c. Although specific secondary structures are not always 
accurately quantifiable, changes in CD spectra are a reliable probe of protein folding or 
unfolding. 
10 
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Figure 6: Different secondary structures produce specific CD spectra.103,104 This figure is 
reproduced from reference 103.103 
1.2.3 Nuclear Magnetic Resonance (NMR) Spectroscopy 
Nuclear magnetic resonance (NMR) spectroscopy is one of the most widely used 
techniques for the structural characterization of small chemical compounds. NMR 
techniques are based on the absorption of radio-frequency (RF) electromagnetic waves by 
atomic nuclei – differing from UV-vis and infrared (IR) spectroscopy which focus on the 
outer electrons.94 An externally applied magnetic field aligns spin 1/2 nuclei, with the 
magnetic moments being parallel or antiparallel to the field. Once aligned, the absorption 
of specific RF frequencies can induce spin flips. The corresponding resonance frequencies 
depend on the chemical environment of each nucleus, as governed by the presence of other 
nuclei and the surrounding electrons.94,105  
Technological advances have drastically improved the ability of NMR spectroscopy to 
elucidate the 3D structures of proteins. 2D and 3D NOESY (nuclear Overhauser effect 
spectroscopy) techniques - among other methods - and analyzing different nuclei in 
addition to 1H, such as 13C and 15N, has proven incredibly useful for protein structural 
studies. Roughly 10% of the coordinates in the Protein Data Bank (PDB) are NMR 
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structures.106–108 NMR is also useful for protein dynamic assays since it can use spin 
relaxation measurements for probing conformational fluctuations.108 Currently existing 
limitations of protein NMR spectroscopy include its relatively low sensitivity, implying 
the need for high analyte concentrations (typically in the high M to low mM range). Some 
proteins tend to aggregate under these high concentration conditions. In addition, the 
applicability of NMR spectroscopy is typically limited to proteins smaller than ~40 kDa. 
1.2.4 X-Ray Crystallography 
X-ray diffraction is used for the structure determination of crystallized proteins. Inverse 
Fourier analysis of the measured diffraction pattern yields electron densities that can 
provide atomically resolved data. For example, John Kendrew solved the structure of 
sperm whale myoglobin using X-ray crystallography and was co-awarded the 1962 
Chemistry Nobel Prize for this achievement.20 Most of the protein structures in the PDB 
were generated using X-ray crystallography. In contrast to NMR spectroscopy, X-ray 
methods can be applied to very large proteins, although, crystallization can be challenging 
(e.g. for membrane proteins).109  
1.3 Mass Spectrometry 
Mass spectrometry (MS) characterizes gaseous ions on the basis of their mass to charge 
ratios (m/z). MS is revered for its high sensitivity, requiring only small amounts of analyte 
at low (M or nM) concentrations. MS can also be paired with complementary analyte 
separation and analysis techniques such as UV-Vis absorption, gas chromatography (GC) 
and liquid chromatography (LC). Fragmentation cells or ion mobility analyzers can be 
added into the mass spectrometer for additional dimensions of analysis. 
As MS has matured in recent years, instruments are now available that have a spectral 
resolution of over a million (resolution is defined by the peak m/z divided by the width at 
50% height). High resolving power affords the ability to distinguish two peaks of similar 
m/z from each other, unlocking analysis potential beyond that of just large protein 
complexes.110  
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Mass spectrometers consist of three main components: ion source, mass analyzer and 
detector. One caveat with MS is that analytes must be transformed into gaseous ions. Up 
until the 1990s, both of these aspects were problematic for MS analyses of large biological 
molecules. Ions generated in the source pass into mass analyzers where they are separated 
based on m/z. The ions then reach a detector where they are translated into spectral signals 
(ion intensity vs m/z). These components are discussed in detail in the following sections. 
1.3.1 Electrospray Ionization (ESI) 
Multiple ionization techniques have been developed that can be applied to different types 
of samples. These include electron impact (EI), atmospheric pressure chemical ionization 
(APCI), chemical ionization (CI), and matrix-assisted laser desorption/ionization 
(MALDI).  The most widely used method, however, is electrospray ionization (ESI). 
Developed by John Fenn,111 ESI in combination with MS has cemented itself as one of the 
most effective methods for protein analysis and earned Fenn the Chemistry Nobel Prize in 
2002 (jointly with Koichi Tanaka). Briefly, ESI is an ionization technique that involves the 
charging of a solution-phase analytes after passing the sample through a charged capillary. 
In positive-ion-mode the resulting gas phase analyte ions are normally multiply protonated 
with a mass-charge ratio  
𝑚
𝑧
=
𝑀 + 𝑧(1.008)
𝑧
 
Equation 1.2 
where M is the neutral analyte mass, z is the number of charges (charge state) and 1.008 
represents the proton mass (Da). Greatly improved analytical workflows can be 
implemented by coupling high pressure liquid chromatography (HPLC) with ESI-MS for 
two-dimensional (solution/gas phase) separations.112 An ESI source in positive ion mode 
(Figure 7) resembles an electrochemical cell where the metal capillary represents the anode 
and the mass spectrometer inlet is the cathode. Solution is injected either directly or by 
HPLC. Charged solution builds up at the tip of the capillary, forming a Taylor Cone. A 
mist of charged droplet is emitted from the Taylor cone. These droplets undergo solvent 
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evaporation until Coulombic repulsion reaches the surface tension of the solution (a 
situation known as “Rayleigh Limit”, defined by Equation 1.3)113  
 
𝑧𝑅 = 
8𝜋
𝑒
√𝜀0𝛾𝑟3  
Equation 1.3 
where zR is the droplet charge at the Rayleigh limit, e is 1.60  10
-19 C, 𝜀0 is the vacuum 
permittivity constant, 𝛾 is the surface tension coefficient, and r is the droplet radius. 
Droplets at the Rayleigh limit undergo jet fission. Ultimately, the combination of solvent 
evaporation and fission events generates nanometer-sized droplets from which analyte ions 
are released into the gas phase. 
 
Figure 7: Schematic depiction of an ESI-source. Analyte solution composed of proteins 
(red) and ions enter the source via a charged metal capillary and aerosolize before 
reaching the inlet. Droplets decrease in size as solution evaporates. 
 
ESI overcomes the difficulties of working with high-mass proteins as they will become 
highly charged, allowing their detection even on mass spectrometers that have limited m/z 
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range.114 Ion release from highly charged nanodroplets has long been thought to proceed 
via one of two mechanisms; the Charged Residue Model (CRM)115 and the Ion Ejection 
Model (IEM).116 Recently, Konermann et al. have proposed an additional pathway, the 
Chain Ejection Model (CEM)117 (Figure 8). The CRM applies mostly to globular protein 
molecules and states that ESI nanodroplets will dry completely, leaving residual charges 
on the globular protein.115 The IEM applies to pre-charged small analytes and ions, 
proposing that as droplet size shrinks, the repulsive forces cause ions to eject from the 
droplet surface.116 The CEM concerns unfolded proteins and large polymers; it is thought 
that hydrophobic surfaces of the analyte will cause the protein chain to migrate toward the 
droplet surface. Subsequently, partial ejection of the protein takes place, and charges 
equilibrate between the droplet and its protruding tail. The protein then separates from the 
droplet in a charge state that is higher than in its folded counterparts.117–119 
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Figure 8: Overview of ESI mechanisms. a) CRM, b) IEM, c) CEM. For details, see text. 
1.3.2 Mass Analyzer 
The mass analyzer component separates ions based on their m/z. Different mass analyzers 
are available; they serve different purposes and have different performance characteristics 
in terms of resolution, transmission efficiency, etc. Common mass analyzers include 
quadrupoles, time-of-flight (TOF) analyzers, Fourier transform ion cyclotron resonance 
(FTICR) instruments, and Orbitraps. Only quadrupoles and TOF systems will be briefly 
discussed. 
Mass analyzers can be used to record mass spectra (known as MS1). Alternatively the mass 
analyzer can be used for selecting precursor ions with specific m/z which are then 
fragmented, followed by fragment ion analysis on a second mass analyzer (MS/MS or 
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MS2), the most common fragmentation method is collision-induced dissociation (CID), 
which involves the activation of analyte ions via collisions with inert gas atoms. These 
collisions cause ion heating, allowing them to overcome activation barriers such that 
decomposition can take place. MS/MS data generated in this way provide information on 
the structure and chemical composition of analytes, such as the sequence of peptides and 
proteins. 
1.3.2.1 Quadrupoles 
Quadrupoles serve important purposes as ion guides, collision cells and as mass filters for 
precursor ion selection. Quadrupoles have a limited mass range and resolution, but they are 
well suited for low-mass ions. Quadrupoles consist of four cylindrical rods with applied 
electrical potentials, AC (or “radio frequency”, RF) and DC voltage, that allow for selective 
transmission of ions. RF/DC ratios remain constant while the amplitude can be varied to 
select different m/z ranges. For any given RF/DC ratio, only ions of one specific m/z adopt 
a stable trajectory and get transmitted, while other ions become unstable collide with the 
rods. Quadrupoles can also be operated as RF-only, where almost all m/z are transmitted. 
In this state, the quadrupole can be used as an ion guide or as a collision cell for ion 
fragmentation.  
Quadrupoles are widely used for precursor ion selection in MS/MS experiments, i.e., prior 
to fragmentation in a collision cell. In triple-quadrupole instruments, the second quadrupole 
is operated in RF- only mode and serves as collision cell. Quadrupoles can also produce a 
mass-spectrum by scanning through different voltages in small steps and measuring ion 
output count with a channel electron multiplier. In summary, quadrupoles are highly 
versatile, making them a common component of various types of mass spectrometers. 
1.3.2.2 Time of Flight Mass Spectrometry (TOF-MS) 
TOF mass spectrometers have a flight tube of length l, in which ions are propelled through 
a field-free vacuum with a velocity (v) that depends on m/z (Equation 1.4). An electrostatic 
pusher applies a uniform orthogonal acceleration voltage pulse ∆𝑈. Subsequently, the 
potential energy of the ion (U z e) is converted to kinetic energy (1/2mv2) such that 
17 
17 
𝑙
𝑡𝑓𝑙𝑖𝑔ℎ𝑡
 =  𝑣 =  √
2∆𝑈𝑧𝑒
𝑚
 
Equation 1.4 
Simple linear TOF analyzers have high transmission but low resolution (~2000). Much 
higher resolution (20000 and higher) can be obtained on a reflectron-TOF system (Figure 
9). Reflectrons act as electrostatic mirrors that reverse the flight direction of ions, based on 
electric potentials applied to the stack of rings that constitutes the reflectron. Reflectrons 
address the problem that ions of the same m/z can be accelerated to slightly different kinetic 
energies in the pusher, thereby causing peak broadening due to different arrival times. The 
reflectron corrects for these differences as ions with the same m/z but different kinetic 
energy will penetrate the reflectron to different depths, thereby ensuring that the ions reach 
the detector after the same time of flight.  
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Figure 9: Schematic cartoon of a reflectron-TOF. Ions enter the TOF chamber and are 
accelerated with a potential energy, ∆𝑈, applied by the pusher. Ions penetrate the 
reflectron to different depths, based on their velocities.  
By combining these components, ESI-Q-TOF mass spectrometers (Figure 10) are 
commonly used by industry professionals and academics alike. From left to right, an 
analyte is ionized via an ESI source and sprayed towards the inlet cone. Ions then 
selectively pass through a quadrupole mass analyzer and into the trap where ions may be 
fragmented and further separated through an (optional) ion mobility chamber. Passing 
through the transfer cell, the ions are given a pulse of energy through the pusher and enter 
the TOF flight tube where they are further separated before reaching the detector. For 
MS/MS analyses, the quadrupole is used to select specific precursor ions (MS1) for 
fragmentation in the trap or transfer cell. The fragments will then be analyzed by the TOF 
(MS2) to complete tandem mass spectrometry. The time it takes for an ion to travel from 
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the pusher to the detector depends on m/z and is described by rearrangement of Equation 
1.4 into Equation 1.5: 
 
√
𝑚
𝑧
=
𝑡𝑓𝑙𝑖𝑔ℎ𝑡√2𝑒𝑈
𝑙
 
Equation 1.5 
Ions of the same m/z are tallied by the detector to create a mass spectrum with m/z on the 
x-axis and counts per second (ion intensity) on the y-axis. 
 
 
Figure 10: Schematic diagram of a quadrupole-time-of-flight (Q-TOF) mass spectrometer.  
1.3.3 Protein Mass Spectrometry  
MS has become widely adopted in proteomics and biophysical chemistry due to its 
robustness, sensitivity, accuracy, and the versatility offered by different MS workflows. 
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Passing the samples through an LC column prior to ESI desalts and purifies analytes, 
thereby generating spectra that have high S/N ratios (Figure 11). 
 
Figure 11: ESI mass spectrum of acid-denatured aMb acquired on a Waters Synapt G2 
following HPLC separation. Charge states z of the individual ions are indicated in red. 
In addition to providing a mass readout, MS instrumentation has developed to be able to 
analyze structure and dynamics, quantify, visualize and identify increasingly complex 
samples.110 ESI-MS also has the ability to analyze proteins in their native conformations 
using gentle conditions that preserve biomolecular structures and interactions.  
One focus area of this thesis is the identification of protein covalent modifications and 
assessment of the subsequent effects on protein structure and dynamics. Below, two of the 
most common MS methods for identifying such covalent modification are briefly 
discussed. 
1.3.3.1 Bottom-Up vs. Top-Down Workflows 
Two main forms of MS/MS can be distinguished, referred to as bottom-up and top-down 
MS. Bottom-up MS employs a protease to digest the protein of interest into peptides prior 
to separation on an LC column, with subsequent ESI-MS/MS analysis (Figure 12). Trypsin 
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is especially useful for determining protein modifications and structure since it is a 
selective protease that only cleaves after lysine and arginine.120,121 However, cleavage 
efficiencies can be perturbed by covalent modification of the positively-charged Lys or 
Arg side chains.122,123 Bottom-up MS has become standard practice in most MS workflows 
because of the dense, site-specific resolution it can provide when coupled to chemical 
labelling methods.124,125 In less well-behaved systems, different proteases may be used in 
combination to increase digestion efficiency and sequence coverage.  
 
Figure 12: Both bottom-up and top-down mass spectrometry workflows. In bottom-up, the 
protein is digested by a protease (e.g., pepsin or trypsin) to create peptides prior to 
separation on an LC column that is coupled to the mass spectrometer. In top-down, the 
intact protein enters the mass spectrometer without prior digestion. Instead, the protein is 
fragmented in the gas phase. 
Rather than employing enzymatic proteolysis, top-down MS involves the fragmentation of 
intact protein via application of techniques such as CID, ETD (electron-transfer 
MS(/MS)
CID
Bottom-Up
Top-Down
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dissociation) or ECD (electron-capture dissociation). In other words, peptides are 
generated in the gas phase rather than in solution.126–128 Pairing top-down MS with ion 
mobility spectrometry (IMS) delivers better resolved peptides, increasing quality of data. 
1.3.3.2 Ion-Mobility Mass Spectrometry 
Ion-mobility spectrometry (IMS) is a gas-phase separation technique that analyzes ions 
based on their collisional-cross-section (CCS) and their charge. CCS characterizes the 
cross-sectional area (i.e., shadow or profile) of an analyte as it passes through the drift tube 
interacting with inert gas. IMS offers a complementary dimension of analysis that can 
differentiate between isomers and conformers, normally unapproachable with traditional 
MS methods.129–131 Combining IMS with LC/MS(MS) provides multidimensional assays 
that offer the ability to decipher very complicated analyte mixtures. IMS is commonly used 
in the context of screening for illicit drugs and explosives. 
IMS involves a drift tube with a homogenous electric field in the presence of a background 
buffer gas (Figure 13). The electric field causes the ions to drift, resulting in separation 
based on different drift velocities. Cyclic-IMS devices have recently been developed to 
achieve unprecedented IMS resolution.132,133 
Different types of IMS instruments have been implemented. For example, drift-tube IMS 
employs a drift tube with a constant field where analytes are in constant axial motion and 
separated based on CCS and drift time.134,135 In contrast, travelling wave IMS (TWIMS) 
employs an alternating electrical field (Figure 13). Ions enter the travelling wave ion guide 
(TWIG) where axial motion is opposed by a drift gas (e.g., N2). RF voltages on the 
electrodes prevent ions from moving in a radial direction, while pulsed DC current moves 
ions axially through the opposing drift gas. Because ions only move when acted upon by 
the electrical field, TWIMS allows for shorter drift tubes while still achieving 
separation.136–139 
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Figure 13: Schematic diagram of a travelling wave ion mobility device (TWIMS). Analytes 
enter a gas-filled ion guide drift tube and are separated by a pulsating electric field as they 
travel toward the detector.  
 
1.4 H/D Exchange Mass Spectrometry 
1.4.1 Fundamentals 
H/D exchange (HDX) methods are widely used for studying protein structure and 
dynamics. Deuterium, 2H, is a heavy isotope of hydrogen that can exchange with hydrogen 
atoms in NH/OH/SH bonds.139 This isotopic labelling opens the possibility to an array of 
different experiments whereby the difference caused by deuteration can be assessed using 
various tools such as NMR or infrared spectroscopy. Most commonly, HDX experiments 
are performed with MS detection, and HDX-MS has become a rapidly growing analysis 
technique for studying protein folding, dynamics, and  interactions.140 
Linderstrøm-Lang pioneered the use of HDX for protein analyses in the mid 20th century 
when working with insulin.141,142 The possibility of being able to study the single-residue 
exchange kinetics by NMR methods was a breakthrough in the 1970s.143,144 Further 
breakthroughs came several years later with the advent of multidimensional NMR 
methods.145 Today, HDX is dominated by LC-MS-based workflows. LC-MS offers the 
24 
24 
ability for peptide level resolution when paired with an acidic protease such as pepsin, 
thereby creating spatially resolved data that reflect dynamic properties of proteins. 
1.4.2 HDX Mechanisms 
When a protein is fully unfolded and solvent exposed, the N-H → N-D amide hydrogen 
transitions take place with a rate constant kch, referred to as the “chemical” rate constant. 
Conversely, the N-H → N-D transition in highly ordered regions is tempered by protein 
conformation and hydrogen bonds involving the amide hydrogen. These protective factors 
cause the deuterium exchange rate constant to fall below that of kch, resulting in an overall 
rate constant kHDX (with kHDX << kch). As proteins fluctuate between different allowed 
conformations, various short-lived ‘open’ states exist that allow HDX to take place, before 
returning to a ‘closed’ conformation. These opening and closing transitions have rate 
constants kop and kcl, respectively. Therefore, the overall deuterium exchange mechanism 
can be described as 
 
𝑁 − 𝐻𝐶𝑙𝑜𝑠𝑒𝑑    𝑁 − 𝐻𝑜𝑝𝑒𝑛   𝑁 − 𝐷𝑜𝑝𝑒𝑛     𝑁 − 𝐷𝑐𝑙𝑜𝑠𝑒𝑑 
𝑘𝑜𝑝 
←   
𝑘𝑐𝑙 
→  
𝐷2𝑂
𝑘𝑐ℎ
→   
𝑘𝑐𝑙 
←  
𝑘𝑜𝑝
→   146 
Equation 1.6 
where the HDX rate constant is 
𝑘𝐻𝐷𝑋 =
𝑘𝑐ℎ𝑘𝑜𝑝
𝑘𝑐ℎ + 𝑘𝑐𝑙  + 𝑘𝑜𝑝
 
Equation 1.7 
HDX can take place in two different kinetic regimes, EX1 and EX2.147,148 Simply put, EX1 
gives rise to bimodal mass distribution due to complete deuteration of open states prior to 
protein refolding (kch >> kcl) such that Equation 1.7 simplifies to 
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𝑘𝐻𝐷𝑋 = 𝑘𝑜𝑝 
Equation 1.8 
In contrast, EX2 shows mass distributions with progressive shifts because deuteration takes 
place slower than closing (kcl >> kch). Under these conditions HDX proceeds with a rate 
constant 
𝑘𝐻𝐷𝑋 = 𝐾𝑜𝑝𝑘𝑐ℎ 
Equation 1.9 
where Kop = (kop/kcl) represents the equilibrium constant of bond opening. Figure14 
provides a visual representation of these two exchange regimes.  
 
Figure 14: The EX2 regime (left) describes continuous HDX under conditions where kcl 
>> kch. The EX1 mechanism (right) applies if kcl << kch giving rise to bimodal deuterium 
uptake distributions. 
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HDX is initiated when proteins are exposed to a D2O-based labelling buffer. This step can 
happen by exposing the sample to a perturbing agent for a brief amount of time before 
pulsing with D2O and quenching (pulse labelling). Alternatively, a protein can be 
continuously incubated in labelling buffer, while aliquots are taken at specific time points 
(continuous labelling).151 Depending on the type of information desired, local 
(peptide/residue level) or global (intact protein) analysis can be conducted by using either 
MALDI-MS or LC-MS. 
Interaction with HDX buffer causes exchange of labile hydrogens in the amide backbone 
and in side chains.141 Side chain deuterium is lost during reverse-phase LC, but backbone 
amide deuterium can be mostly retained and analyzed by ESI-MS.152–154 HDX rates depend 
on pH and temperature, as well as flanking side chains.146,153–155 This implies that it is 
imperative to control experimental factors such as pH, quenching temperature, LC and 
column temperature.156 Exchange is slowest at pH ~2.5 where kch attains its minimum 
(Figure 15) between acid, base and water catalysis (Equation 1.10) thus presenting an 
optimum range for quenching and analysis.96, 97  
 
𝑘𝑐ℎ = 𝑘𝑎𝑐𝑖𝑑[𝐻
+] + 𝑘𝑏𝑎𝑠𝑒[𝑂𝐻
−] + 𝑘𝑤[𝐻2𝑂] 
Equation 1.10 
The dependence on temperature can be approximated by the Arrhenius equation 
𝑘𝑐ℎ = 𝐴𝑒
−
𝐸𝑎
𝑅𝑇 
Equation 1.11 
where A is a constant pre-exponential factor, Ea is activation energy, R is the gas constant 
and T is the temperature.158 Hence, HDX quenching is performed by lowering the solution 
temperature to ~0 C, in conjunction with acidification. The quenched samples can then be 
stored in liquid nitrogen prior to analysis.   
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Figure 15: Dependence of kch on pH, revealing the existence of a global minimum at 
around pH 2.4-3. This presents the pH used for HDX quenching.157 This figure is 
reproduced from reference.157 
1.4.3 HDX Data Analysis 
HDX-MS is usually performed in a bottom-up fashion.159 In these experiments, a protease 
(usually pepsin) is used to create peptide fragments from a protein after HDX, resulting 
spatially-resolved data. Top-down HDX-MS represents an alternative workflow that uses 
gas phase fragmentation of proteins without prior proteolysis, but this approach is less 
commonly applied.160 In this thesis we will focus exclusively on continuous bottom-up 
HDX-MS. 
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Although efforts are made to minimize back exchange during LC, some level of deuterium 
loss is unavoidable. To account for these effects, two control measurements are performed 
in addition to the “regular” HDX time points. m100 represents a fully deuterated sample, 
and m0, which represents an ambient baseline of deuteration under quenched conditions. 
The equation for percentage of deuteration (Dt) for any time point (t) is then calculated as 
𝐷𝑡 =
𝑚𝑡 − 𝑚0
𝑚100  −  𝑚0
 × 100% 
Equation 1.12 
where m represents the observed centroid mass of the peptide.161,162 Generally, Dt will be 
presented as a function of exposure time for individual peptides. Creating and comparing 
uptake plots and superimposing the results on protein PDB structures using a colour 
gradient can help visualize uptake differences. The effects of oxidative damage can then 
be rationalized relative to structural influences or other factors. 
If desired, the amides in any given peptide can be described experimentally by fitting the 
HDX profiles to a tri-exponential expression. This involves characterizing all the different 
amides and their kHDX values via average values according to fast (N1), medium (N2) or 
slow (N3) 
146,161,163 
𝐷𝑡 = 𝑁1[1 − 𝑒
−𝑘1𝑡] + 𝑁2[1 − 𝑒
−𝑘2𝑡] + 𝑁3[1 − 𝑒
−𝑘3𝑡] 
Equation 1.13 
However, depending on the kinetic behavior observed, single or double exponential 
expressions may be suitable as well. 
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1.5 Scope of Thesis 
 
To better understand effects of oxidative damage, the current work focused on Mb as a 
simple model protein. We tested the effects of various oxidants including H2O2, 
chloramine-T, and tert-butyl hydroperoxide (TBHP) to identify reaction conditions in an 
effort to produce relatively homogenous reaction products that could then be interrogated 
by a range of MS-based analytical workflows (including LC-MS/MS, HDX-MS, and 
IM/MS). TBHP was identified as the most suitable reagent to produce a controlled 
oxidation product; minimizing unoxidized fraction and products of overoxidation. Previous 
studies in the literature165,166 suggested TBHP to be a methionine specific oxidizing agent; 
however; through the rigorous bottom-up and top-down testing of this project, we 
debunked this notion.  
A key challenge to HDX-MS experiments with oxidized protein is the occurrence of peak 
broadening and peak splitting. These phenomena interfere with spectral data analysis, as 
most ROS produce a heterogeneous mix of oxidized proteoforms. For this reason, the 
application of HDX-MS to oxidized protein has been avoided by other laboratories, leaving 
a gap of information regarding pathologically relevant systems. This work aims to begin 
closing existing literature gaps through the rigorous structural analysis of the model 
protein, Mb, after oxidation. By aiming to overcome the challenges associates with HDX-
MS of oxidized samples, this work sheds light upon the efficacy of the method in depicting 
dynamic alterations, secondary to covalent modification. By demonstrating analyses using 
a protein that is only specifically modified in a few known sites, further works may assess 
additive effects of further oxidative-damage events, leading up to the point of aggregation. 
The combination of various analytical approaches in this work may serve as an outline for 
further studies on other oxidatively damaged proteins that are relevant for key pathological 
pathways. 
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DOI:10.1021/acs.jproteome.7b00330. 
59 A. M. R. De Graff, M. J. Hazoglou and K. A. Dill, Structure, 2016, 24, 329–336. 
34 
34 
60 E. R. Stadtman, Protein Oxidation and Aging, 1992, vol. 257. 
61 J. Hallwell, Barry; Gutteridge, Free Radicals in Biology and Medicine, Oxford 
University Press, New York, NY, 5th edn., 2015. 
62 T. J. A. Höhn and T. Grune, Redox Biol., 2014, 2, 99–104. 
63 C. C. W. Verlackt, W. Van Boxem, D. Dewaele, F. Lemiere, F. Sobott, J. Benedikt, 
E. C. Neyts and A. Bogaerts, J. Phys. Chem. C, 2017, 121, 5787–5799. 
64 E. R. Stadtman and R. L. Levine, Amino Acids, 2003, 25, 207–218. 
65 L. Frémont, Life Sci., 2000, 66, 663–673. 
66 M. Jang, L. Cai, G. O. Udeani, K. V Slowing, C. F. Thomas, C. W. Beecher, H. H. 
Fong, N. R. Farnsworth, A. D. Kinghorn, R. G. Mehta, R. C. Moon and J. M. 
Pezzuto, Science (80-. )., 1997, 275, 218–20. 
67 L. Hung, J.-K. Chen, S.-S. Huang, R.-S. Lee and M.-J. Su, Cardiovasc. Res., 2000, 
47, 549–555. 
68 J. A. Baur and D. A. Sinclair, Nat. Rev. Drug Discov., 2006, 5, 493–506. 
69 C. A. de la Lastra and I. Villegas, Biochem. Soc. Trans., 2007, 35, 1156–60. 
70 D. E. Heppner, C. M. Dustin, C. Y. Liao, M. Hristova, C. Veith, A. C. Little, B. A. 
Ahlers, S. L. White, B. Deng, Y. W. Lam, J. N. Li and A. van der Vliet, Nat. 
Commun., , DOI:10.1038/s41467-018-06790-1. 
71 A. Höhn, J. König and T. Grune, J. Proteomics, 2013, 92, 132–159. 
72 K. J. A. Davies, Biochimie, 2001, 301–310. 
73 P. Ricchiuto, A. V Brukhno and S. Auer, J. Phys. Chem. B, 2012, 116, 5384–5390. 
74 K. K. Sharma and P. Santhoshkumar, Biochim. Biophys. Acta - Gen. Subj., 2009, 
1790, 1095–1108. 
35 
35 
75 J. L. Louie, R. J. Kapphahn and D. A. Ferrington, Exp. Eye Res., 2002, 75, 271–284. 
76 A. Spector, FASEB, 1995, 9, 1173–82. 
77 D. Eliezer, J. Yao, H. J. Dyson and P. E. Wright, Nat. Struct. Biol., 1998, 5, 148–
155. 
78 D. Eliezer and P. E. Wright, J. Mol. Biol., 1996, 263, 531–538. 
79 P. A. Jennings and P. E. Wright, Science (80-. )., 1993, 262, 892–896. 
80 S. Cavagnero, Y. Thériault, S. S. Narula, H. J. Dyson and P. E. Wright, Protein Sci., 
2000, 9, 186–193. 
81 E. E. Scott, E. V Paster and J. S. Olson, J. Biol. Chem., 2000, 275, 27129–27136. 
82 S. V Evans and G. D. Brayer, J. Mol. Biol., 1990, 213, 885–897. 
83 A. Ostermann, R. Waschipky, F. G. Parak and G. U. Nienhaus, Nature, 2000, 404, 
205–208. 
84 M. Schmidt, K. Nienhaus, R. Pahl, A. Krasselt, S. Anderson, F. Parak, G. U. 
Nienhaus and V. Srajer, Proc. Nat. Acad. Sci., 2005, 102, 11704–11709. 
85 R. S. Johnson and K. A. Walsh, Protein Sci., 1994, 3, 2411–2418. 
86 G. A. Ordway and D. J. Garry, J. Exp. Biol., 2004, 207, 3441 LP – 3446. 
87 J. Pan, J. Han, C. H. Borchers and L. Konermann, J. Am. Chem. Soc., 2009, 131, 
12801–12808. 
88 C. Faustman, Q. Sun, R. Mancini and S. P. Suman, Meat Sci., 2010, 86, 86–94. 
89 T. Wazawa, A. Matsuoka, G. Tajima, Y. Sugawara, K. Nakamura and K. Shikama, 
Biophys. J., 1992, 63, 544–50. 
90 M. A. Sowole, S. Vuong and L. Konermann, Anal. Chem., 2015, 87, 9538–9545. 
36 
36 
91 A. J. Szuchman-Sapir, D. I. Pattison, N. A. Ellis, C. L. Hawkins, M. J. Davies and 
P. K. Witting, Free Radic. Biol. Med., 2008, 45, 789–798. 
92 T. R. n Ulrike B. Hendgen-Cotta, Malte Kelm, Free Radic. Biol. Med., 2014, 73, 
252–259. 
93 J. B. Wittenberg and B. A. Wittenberg, J. Exp. Biol., 2003, 206, 2011 LP – 2020. 
94 D. A. Skoog, Principles of Instrumental Analysis, Brooks/Cole Thomson Learning, 
Toronto, 1998. 
95 F. C. Strong, Anal. Chem., 1952, 24, 338–342. 
96 S. C. Gill and P. H. von Hippel, Anal. Biochem., 1989, 182, 319–326. 
97 W. Zheng, N. Shan, L. Yu and X. Wang, Dye. Pigment., 2008, 77, 153–157. 
98 S. W. Kelly, T. J. Jess and N. C. Price, Biochim. Biophys. Acta, 2005, 1751, 119–
139. 
99 S. Kelly and N. Price, Curr. Protein Pept. Sci., 2000, 1, 349–384. 
100 K. Nakanishi, N. Berova and R. W. Woody, Circular Dichroism, VCH, New York 
Weinheim Cambridge, 1994. 
101 N. J. Greenfield, Nat. Protoc., 2006, 1, 2876–2890. 
102 J. P. Hennessey and W. C. Johnson, Biochemistry, 1981, 20, 1085–1094. 
103 N. V. Bhagavan, Medical biochemistry, Harcourt/Academic Press, 2002. 
104 W. C. Johnson, Proteins Struct. Funct. Genet., 1990, 7, 205–214. 
105 D. I. Hoult and B. Bhakar, NMR Signal Reception: Virtual Photons and Coherent 
Spontaneous Emission, John Wiley & Sons, Inc. Concepts Magn Reson, 1997, vol. 
9. 
37 
37 
106 G. Wagner and K. Wüthrich, J. Mol. Biol., 1982, 155, 347–366. 
107 K. Wüthrich, in Encyclopedia of Life Sciences (www.els.net), Nature Pulishing 
Group, London, 2001. 
108 D. S. Wishart, B. D. Sykes and F. M. Richards, J. Mol. Biol., 1991, 222, 311–333. 
109 D. M. Rosenbaum, V. Cherezov, M. A. Hanson, S. G. F. Rasmussen, F. S. Thian, T. 
S. Kobilka, H. Choi, X. Yao, W. I. Weis, R. C. Stevens and B. K. Kobilka, Science 
(80-. )., 2007, 318, 1266–1273. 
110 B. Domon and R. Aebersold, Science (80-. )., 2006, 312, 212–217. 
111 J. B. Fenn, M. Mann, C. K. Meng, S. F. Wong and C. M. Whitehouse, Science (80-
. )., 1989, 246, 64–71. 
112 B. A. Thomson, J. Am. Soc. Mass Spectrom., 1998, 9, 187–193. 
113 Lord Rayleigh, Philos. Mag., 1882, 14, 184–186. 
114 J. B. Fenn, Angew. Chem. Int. Ed., 2003, 42, 3871–3894. 
115 M. Dole, L. L. Mack, R. L. Hines, R. C. Mobley, L. D. Ferguson and M. B. Alice, 
J. Chem. Phys., 1968, 49, 2240–2249. 
116 J. V Iribarne and B. A. Thomson, J. Chem. Phys., 1976, 64, 2287–2294. 
117 L. Konermann, E. Ahadi, A. D. Rodriguez and S. Vahidi, Anal. Chem., 2013, 85, 2–
9. 
118 P. Kebarle and U. H. Verkerk, Mass Spectrom. Rev., 2009, 28, 898–917. 
119 F. J. de la Mora, Anal. Chim. Acta, 2000, 406, 93–104. 
120 H. K. Hustoft, H. Malerod, S. R. Wilson, L. Reubsaet, E. Lundanes and T. 
Greibrokk, 4 A Critical Review of Trypsin Digestion for LC-MS Based Proteomics, 
. 
38 
38 
121 J. V Olsen, S. Ong and M. Mann, Mol. Cell. Proteomics, 2004, 3, 608–614. 
122 B. F. Shaw, H. Arthanari, M. Narovlyansky, A. Durazo, D. P. Frueh, M. P. Pollastri, 
A. Lee, B. Bilgicer, S. P. Gygi, G. Wagner and G. M. Whitesides, J. Am. Chem. 
Soc., 2010, 132, 17411–17425. 
123 D. D. Gouveia, A. M. N. Silva, R. Vitorino, M. Rosário, M. Domingues and P. 
Domingues, Eur. J. Mass Spectrom., 2014, 20, 271–278. 
124 K. M. Burns, M. Rey, C. A. H. Baker and D. C. Schriemer, Mol. Cell. Proteomics, 
2013, 12, 539–548. 
125 L. C. Gillet, A. Leitner and R. Aebersold, in Annu. Rev. Anal. Chem., eds. P. W. 
Bohn and J. E. Pemberton, Annual Reviews, Palo Alto, 2016, vol. 9, pp. 449–472. 
126 F. Lanucara and C. E. Eyers, Mass Spectrom. Rev., 2013, 32, 27–42. 
127 W. Cui, H. W. Rohrs and M. L. Gross, Analyst, 2011, 136, 3854–3864. 
128 J. Pan and C. H. Borchers, Proteomics, 2013, 13, 974–981. 
129 A. B. Kanu, P. Dwivedi, M. Tam, L. M. Matz and H. H. Hill, J. Mass Spectrom., 
2008, 43, 1–22. 
130 B. T. Ruotolo, J. L. P. Benesch, A. M. Sandercock, S.-J. Hyung and C. V Robinson, 
Nat. Protoc., 2008, 3, 1139–1152. 
131 Y. Sun, S. Vahidi, M. A. Sowole and L. Konermann, J. Am. Soc. Mass Spectrom., 
2016, 27, 31–40. 
132 C. Eldrid, J. Ujma, S. Kalfas, N. Tomczyk, K. Giles, M. Morris and K. Thalassinos, 
Anal. Chem., 2019, 91, 7554–7561. 
133 J. Ujma, D. Ropartz, K. Giles, K. Richardson, D. Langridge, J. Wildgoose, M. Green 
and S. Pringle, J. Am. Soc. Mass Spectrom., 2019, 30, 1028–1037. 
134 J. L. Wildgoose, K. Giles, S. D. Pringle, S. Koeniger, S. J. Valentine, R. H. Bateman 
39 
39 
and D. E. Clemmer, in Proc. 54th ASMS Conference on Mass Spectrometry & Allied 
Topics, ASMS, Seattle, WA, May 28–June 1st, 2006. 
135 S. M. Stow, T. J. Causon, X. Y. Zheng, R. T. Kurulugama, T. Mairinger, J. C. May, 
E. E. Rennie, E. S. Baker, R. D. Smith, J. A. McLean, S. Hann and J. C. Fjeldsted, 
Anal. Chem., 2017, 89, 9048–9055. 
136 C. A. Scarff, K. Thalassinos, G. R. Hilton and J. H. Scrivens, Rapid Commun. Mass 
Spectrom., 2008, 22, 3297–3304. 
137 P. Liuni, B. Deng and D. J. Wilson, Analyst, 2015, 14, 6973–6979. 
138 J. P. Williams, J. A. Lough, I. Campuzano, K. Richardson and P. J. Sadler, Rapid 
Commun. Mass Spectrom., 2009, 23, 3563–3569. 
139 K. Giles, J. P. Williams and I. Campuzano, Rapid Commun. Mass Spectrom., 2011, 
25, 1559–1566. 
140 J. J. Englander, C. Del Mar, W. Li, S. W. Englander, J. S. Kim, D. D. Stranz, Y. 
Hamuro and V. L. Woods, Proct. Nat. Acad. Sci., 2003, 100, 7057–7062. 
141 G. F. Pirrone, R. E. Iacob and J. R. Engen, Anal. Chem., 2015, 87, 99–118. 
142 A. Hvidt and K. Linderstrom-Lang, Biochem. Biophys. Acta, 1954, 14, 574–575. 
143 K. Linderstrøm-Lang, in Symposium on Protein Structure, ed. A. Neuberger, 
Methuen & CO LTD, London, 1958, pp. 23–34. 
144 S. W. Englander, L. M. Bai and T. R. Sosnick, Protein Sci., 1997, 6, 1101–1109. 
145 S. W. Englander, T. R. Sosnick, J. J. Englander and L. Mayne, Curr. Opin. Struct. 
Biol., 1996, 6, 18–23. 
146 G. Wagner and K. Wüthrich, Methods Enzymol., 1986, 131, 307–326. 
147 L. Konermann, J. Pan and Y. H. Liu, Chem. Soc. Rev., 2011, 40, 1224–1234. 
40 
40 
148 L. Konermann, X. Tong and Y. Pan, J. Mass Spectrom., 2008, 43, 1021–1036. 
149 T. E. Wales and J. R. Engen, Mass Spectrom. Rev., 2006, 25, 158–170. 
150 D. D. Weis, T. E. Wales, J. R. Engen, M. Hotchko and L. F. Eyck, J. Am. Soc. Mass 
Spectrom., 2006, 17, 1498–1509. 
151 J. Zhang, P. Ramachandran, R. Kumar and M. L. Gross, J. Am. Soc. Mass Spectrom., 
2013, 24, 450–453. 
152 Y. Deng, Z. Zhang and D. L. Smith, J. Am. Soc. Mass Spectrom., 1999, 10, 675–
684. 
153 B. T. Walters, A. Ricciuti, L. Mayne and S. W. Englander, J. Am. Soc. Mass 
Spectrom., 2012, 23, 2132–2139. 
154 K. Dharmasiri and D. L. Smith, Anal. Chem., 1996, 68, 2340–2344. 
155 Z. Zhang and D. L. Smith, Protein Sci., 1993, 2, 522–531. 
156 Y. Bai, J. S. Milne, L. Mayne and S. W. Englander, Proteins Struct., Funct., Genet., 
1993, 17, 75–86. 
157 J. D. Venable, L. Okach, S. Agarwalla and A. Brock, Anal. Chem., 2012, 84, 9601–
9608. 
158 D. L. Smith, Y. Deng and Z. Zhang, J. Mass Spectrom., 1997, 32, 135–146. 
159 L. Swint-Kruse and A. D. Robertson, Biochemistry, 1996, 35, 171–180. 
160 N. L. Kelleher, H. Y. Lin, G. A. Valaskovic, D. J. Aaserud, E. K. Fridriksson and F. 
W. McLafferty, J. Am. Chem. Soc., 1999, 121, 806–812. 
161 J. Liu and L. Konermann, J. Am. Soc. Mass Spectrom., 2009, 20, 819–828. 
162 A. J. Percy, M. Rey, K. M. Burns and D. C. Schriemer, Anal. Chim. Acta, 2012, 721, 
7–21. 
41 
41 
163 G. R. Masson, J. E. Burke, N. G. Ahn, G. S. Anand, C. Borchers, S. Brier, G. M. 
Bou-Assaf, J. R. Engen, S. W. Englander, J. Faber, R. Garlish, P. R. Griffin, M. L. 
Gross, M. Guttman, Y. Hamuro, A. J. R. Heck, D. Houde, R. E. Iacob, T. J. D. 
Jørgensen, I. A. Kaltashov, J. P. Klinman, L. Konermann, P. Man, L. Mayne, B. D. 
Pascal, D. Reichmann, M. Skehel, J. Snijder, T. S. Strutzenberg, E. S. Underbakke, 
C. Wagner, T. E. Wales, B. T. Walters, D. D. Weis, D. J. Wilson, P. L. Wintrode, 
Z. Zhang, J. Zheng, D. C. Schriemer and K. D. Rand, Nat. Methods, 2019, 16, 595–
602. 
164 D. D. Weis, Hydrogen exchange mass spectrometry of proteins : fundamentals, 
methods, and applications, John Wiley & Sons, 2016. 
165 M. Imiołek, G. Karunanithy, W.-L. Ng, A. J. Baldwin, V. Gouverneur and B. G. 
Davis, J. Am. Chem. Soc., 2018, 140, 1568–1571. 
166 R. G. Keck, Anal. Biochem., 1996, 236, 56–62. 
167 W. E. Balch, R. I. Morimoto, A. Dillin and J. W. Kelly, Science (80-. )., 2008, 319, 
916–919. 
168 A. G. Madian and F. E. Regnier, J. Proteome Res., 2010, 9, 3766–3780. 
169 P. R. Angelova and A. Y. Abramov, FEBS Lett., 2018, 592, 692–702. 
170 I. Verrastro, S. Pasha, K. T. Jensen, A. R. Pitt and C. M. Spickett, Biomolecules, 
2015, 5, 378–411. 
171 B. Halliwell and M. Whiteman, Br. J. Pharmacol., 2004, 142, 231–255. 
172 H. Mirzaei and F. Regnier, J. Chromatogr. A, 2006, 1134, 122–133. 
173 M. J. Davies, Biochim. Biophys. Acta - Proteins Proteomics, 2005, 1703, 93–109. 
174 I. Dalle-Donne, R. Rossi, D. Giustarini, A. Milzani and R. Colombo, Clin. Chim. 
Acta, 2003, 329, 23–38. 
42 
42 
175 X. Li, Z. Li, B. Xie and J. S. Sharp, J. Am. Soc. Mass Spectrom., 2013, 24, 1767–
1776. 
176 E. Shacter, Drug Metab. Rev., 2000, 32, 307–326. 
177 M. Karplus and J. A. McCammon, Ann. Rev. Biochem., 1983, 53, 263–300. 
178 L. Konermann, J. Pan and Y. H. Liu, Chem. Soc. Rev., 2011, 40, 1224–1234. 
179 L. Konermann, S. Vahidi and M. A. Sowole, Anal. Chem., 2014, 86, 213–232. 
180 M. Imiołek, G. Karunanithy, W.-L. Ng, A. J. Baldwin, V. Gouverneur and B. G. 
Davis, , DOI:10.1021/jacs.7b10230. 
181 R. Hutchins, M. Hutchins and B. Trost, Comprehensive organic synthesis: 
Reduction of C=X to CH2 by Wolff-Kishner and Other Hydrazone Methods, 8th 
edn., 1991. 
182 G. Schneider and G. A. Sprenger, Enzym. Kinet. Mech., 2003, 197–201. 
183 T. Matsui, S. Ozaki and Y. Watanabe, J. Am. Chem. Soc., 1999, 121, 9952–9957. 
184 V. Yin, G. S. Shaw and L. Konermann, J. Am. Chem. Soc., 2017, 139, 15701–15709. 
185 V. Yin, S. H. Mian and L. Konermann, Chem. Sci., , DOI:10.1039/C8SC03624A. 
186 R. G. Keck, Anal. Biochem., 1996, 236, 56–62. 
187 C. Giulivi and K. J. Davies, J. Biol. Chem., 2001, 276, 24129–36. 
188 D. Tew and P. R. Ortiz De Montellano, J. Biol. Chem., 1988, 263, 17880–17886. 
189 A. Bachi, I. Dalle-Donne and A. Scaloni, Chem. Rev., 2013, 113, 596–698. 
190 D. D. Gouveia, A. M. N. Silva, R. Vitorino, M. R. M. Domingues and P. Domingues, 
Eur. J. Mass Spectrom., 2014, 20, 271–278. 
191 P. Wood, Humana Press, New York, NY, 2017, pp. 229–232. 
43 
43 
192 O. H. Wheeler and O. Rosado-Lojo, Tetrahedron, 1962, 18, 477–482. 
193 D. A. Polasky, F. Lermyte, M. Nshanian, F. Sobott, P. C. Andrews, J. A. Loo and 
B. T. Ruotolo, Anal. Chem, 2018, 90, 2756–2764. 
194 D. A. Polasky, F. Lermyte, M. Nshanian, F. Sobott, P. C. Andrews, J. A. Loo and 
B. T. Ruotolo, Anal. Chem., 2018, 90, 2756–2764. 
44 
44 
 
2 Analysis of Oxidatively Modified Myoglobin by 
Complementary Mass Spectrometry Techniques 
2.1 Introduction 
As humans and other organisms age, oxidatively damaged proteins can accumulate in the 
body as the result of encounters with ROS. Oxidative damage contributes to a range of age-
related pathologies, as modified proteins may exhibit impaired function.1–4 This poses 
particular risks to tissues where proteins are not continuously regenerated. The brain is 
especially susceptible to oxidative damage due to its high demand for oxygen, leading to 
various pathologies as discussed in chapter 1.1.3.5  
Protein oxidation (in particular, carbonyl formation) has long been viewed as a hallmark 
for measuring the extent of oxidative stress and damage to cells.6–11 Quantification can be 
achieved through a variety of methods such as OxyBlots, derivatization with 2,4-
dinitrophenylhydrazine, antibody tagging, and covalent labelling with reagents such as 
Girard’s reagent and biotin hydrazide.8,9,12,13 Alternatively, MS lends itself as an 
exceptionally sensitive tool for the identification and quantification of oxidative 
modifications. As outlined in Chapter 1, protein function is governed by protein structure 
and dynamics.14–17 Studying the effects of oxidative damage on protein structural dynamics 
is therefore imperative for the development of treatments to combat oxidation-induced 
pathologies. 
MS offers a number of avenues to probe protein oxidation. Traditional LC-MS/MS bottom-
up workflows are widely used, but they may yield incomplete information due to protease 
inefficiency as a result of oxidative modifications. Top-down MS can potentially overcome 
this hurdle, yielding residue-resolved information regarding the exact nature of oxidation 
events. IM-MS can provide additional insight, probing the effects of oxidative 
modifications on the gas phase structures (CCS) of proteins. Of particular interest is the 
ability to acquire information on conformational dynamics with high spatial resolution by 
using HDX-MS.18–20 Surprisingly, this particular technique is under-utilized when it comes 
to the characterization of oxidatively modified proteins. Possible reasons for the scarcity 
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of HDX-MS data in this context include the complexity of the samples, as well as the 
cumbersome data analysis and sample conditioning. The current work aims to overcome 
some of these complications in pursuit of comprehensive protein analysis. 
As discussed in 1.1.3, protein oxidative damage typically results from oxygen-based 
radicals and other ROS. One of the main biological sources of radicals is the production of 
hydroxyl radical by metal catalyzed oxidation of H2O2, otherwise known as Fenton 
Chemistry (Scheme 1, below).21–23 Heme proteins such as Mb, hemoglobin and various 
cytochromes can be the source of the Fe2+/3+ required for these processes. 
𝐹𝑒2+ + 𝐻2𝑂2 → 𝐹𝑒
3+ + 𝐻𝑂• + 𝐻𝑂− 
𝐹𝑒3+ + 𝐻2𝑂2 → 𝐹𝑒
2+ + 𝐻𝑂𝑂• + 𝐻+ 
________________________________________________________________________ 
2𝐻2𝑂2 → 𝐻𝑂
• + 𝐻𝑂𝑂• + 𝐻2𝑂 
 
Scheme 1: Formation of oxygen-based radicals from H2O2 via Fenton Chemistry. 
The high second order reaction constants for the reaction of peroxide radicals with protein 
side chains results in low specificity and reproducibility, because the ROS produced in this 
way cause a wide range of different protein modifications.10,23 The non-uniform and highly 
heterogeneous nature of the oxidation products generated by these processes makes their 
analytical characterization very difficult. For initial method development, it would be 
desirable to use an oxidant that is more targeted and that produces relatively homogeneous 
oxidation products. For this reason, we did not focus our attention on H2O2, but instead 
explored alternative options. 
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Figure 1: Chemical structure of hydrogen peroxide (top) and tert-Butyl hydroperoxide 
(TBHP - bottom) 
TBHP (Figure 1) has been reported by Keck to be a methionine-specific oxidizing agent, 
targeting solvent exposed methionine residues in native recombinant interferon  (rIFN-) 
and recombinant tissue-type plasminogen activator (rt-PA).24 Similarly, experiments by 
Imiołek et al. on Mb yielded promising results that indicated specific methionine oxidation 
by TBHP.25 Similar to H2O2, TBHP is susceptible to oxy and peroxide radical formation 
via Fenton chemistry. (CH3)3COO•
 and (CH3)3CO• can be produced in situ at heme iron 
centers as outlined below: 
𝐹𝑒2+ + (𝐶𝐻3)3𝐶𝑂𝑂𝐻 → 𝐹𝑒
3+ + (𝐶𝐻3)3𝐶𝑂
• +𝐻𝑂− 
𝐹𝑒3+ + (𝐶𝐻3)3𝐶𝑂𝑂𝐻 → 𝐹𝑒
2+ + (𝐶𝐻3)3𝐶𝑂𝑂
• + 𝐻+ 
________________________________________________________________________ 
2 (𝐶𝐻3)3𝐶𝑂𝑂𝐻 → (𝐶𝐻3)3𝐶𝑂
• + (𝐶𝐻3)3𝐶𝑂𝑂
• + 𝐻2𝑂 
 
Scheme 2: Formation of oxygen-based radicals from TBHP via Fenton Chemistry. 
Due to the inherent steric obstruction of tert-butoxyl radicals, second order rate constants 
are lower than those of hydroxyl radicals, thereby promoting the formation of oxidation 
patterns that are more straightforward. The reported selectivity and reproducibility of 
TBHP 24,25 makes this reagent a promising model compound for the experiments of this 
O
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work, and it was therefore used in our experiments for inducing protein oxidative 
modifications. 
Instead of studying actual in vivo protein oxidation, the current work employed Mb as a 
model system to examine the effects of TBHP exposure in vitro. We relied on the presence 
of heme iron in Mb to induce Fenton chemistry which causes oxidative damage of the 
protein. The oxidized Mb generated in this way then served as a testbed to adapt and 
optimize a comprehensive set of MS-based workflows for characterizing the effects of 
protein oxidation in solution and in the gas phase. 
2.2 Methods 
2.2.1 Materials 
BioUltra ≥ 98% (SDS-PAGE) hMb from equine skeletal muscle, Luperox® TBH70X 
(tert-Butyl hydroperoxide solution – TBHP), Girard’s Reagent T (GRT, carboxymethyl-
trimethylammonium-hydrazide chloride), and D2O were sourced from Sigma Aldrich (St. 
Louis, MO). HCl was purchased from Caledon (Georgetown, ON, Canada). LC-MS grade 
H2O was acquired from Optima (Fair Lawn, NJ). Trypsin Gold, mass spectrometry grade, 
was obtained from Promega (Madison, WI). All pH values were measured with a Fisher 
(Waltham, MA) AB15 pH meter. 
2.2.2 Protein Oxidation 
Each TBHP-oxidized protein sample was prepared by creating a solution containing 100 
M myoglobin, 40 mM pH 6.0 ammonium acetate buffer and 2500 M TBHP oxidant. 
The samples were immediately placed on ice once mixed and left to react for 60 minutes, 
in accordance with reference 25.25 The reaction was quenched by dialysis in 10 kDa 
MWCO filters via a 13 g, 15-minute centrifugal spin-down, repeated three times. Control 
protein was prepared under identical conditions, except an equivalent volume of water was 
added in place of TBHP oxidant. 
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2.2.3 Isotopic Modelling 
Protein Prospector is a software package created by the University of California at San 
Francisco where isotopic mass distributions are calculated based on chemical composition. 
Theoretical mass distributions were normalized and plotted against experimental data to 
model spectra accordingly.  
2.2.4 Tryptic Digestion 
Digestion samples were prepared using Trypsin Gold, 20% acetonitrile, pH 7.7 ammonium 
bicarbonate 12.5mM, and 1:20 protein:protease, incubated at 37ºC for 24h. The samples 
were quenched with 2.5% formic acid. Waters reverse phase nanoACQUITY UPLC 
separation employed a BEH 1.7 m, 1  100 mm C18 column, prior to MS/MS (MS
E) 
analysis. Waters ProteinLynx Global SERVER is the main data interpretation suite for 
Waters instruments and was used to decipher and match MSE data to database values for 
tryptic myoglobin peptides, where covalent protein modifications can be accounted for. All 
LC-MS peaks were then manually analyzed to confirm any reported peptides to avoid false 
positives and negatives. 
2.2.5 Covalent Labelling of Oxidatively Modified Protein 
Control and oxidized protein stocks were added to a 400 L solution containing 80 mM of 
Girard’s reagent T (GRT), 10 M protein, and 50 mM pH 7.4 phosphate buffer. The 
samples were incubated at room temperature overnight. To affix the GRT tag, the 
hydrazone bond was reduced using excess sodium borohydride on ice for 1 h.26,27 
Following, the reaction was quenched by dialysis in 10 kDa MWCO filters via a 13 g, 15-
minute centrifugal spin-down repeated three times. 
2.2.6 Top-Down CID-IM-MS 
Experiments were performed on a Synapt G2-Si ESI quadrupole-time-of-flight instrument 
set to resolution mode. The instrument parameters were set as follows: cone voltage 20 V, 
ESI voltage 2.8 kV, source temperature 80 ºC and desolvation temperature 250 ºC. 10 M 
protein samples were prepared in 50:50 H2O:ACN with 0.1% formic acid, and infused 
directly by way of a syringe pump, flowing at 5 L/min. MS/MS experiments by collision-
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induced-dissociation (CID) utilized argon collision gas using 27 V to fragment quadrupole-
selected 25+ protein ions. IMS separation following fragmentation was performed in N2 
buffer gas with corresponding wave velocity of 350 m s-1 and wave height of 13 V.  
2.2.7 HDX/MS 
A 1000 L HDX samples were prepared containing 89% v/v D2O, 50 mM potassium-
phosphate buffer and 5 M protein. 100 L aliquots were taken from this stock at specific 
time intervals and quenched in sample tubes containing chilled hydrochloric acid to a 
predetermined pH of 2.5 and immediately flash frozen in liquid nitrogen. m0 samples were 
used to present a baseline for deuterium uptake by exposing the protein to deuterium buffer 
under pre-quenched conditions. These samples were created mimicking the composition 
of prior 100 L aliquot time interval samples, in that m0 samples were composed of 89% 
v/v D2O, 5 M protein, 50 mM potassium-phosphate buffer and sufficient hydrochloric 
acid to reach pH 2.5. m100 samples, which represent fully deuterated protein, were left to 
incubate overnight at 40 C. At pH 2.5, m100 samples represent maximum experimental 
uptake of denatured protein. 
 
Prior to injection, each frozen sample was rapidly thawed to ~ 0 ºC. Bottom-up HDX-MS 
was performed using a nanoACQUITY UPLC equipped HDX Manager, mated to a Synapt 
G2 ESI quadrupole-time-of-flight mass spectrometer (Waters, Milford, MA). Online 
digestion was performed at 15 ºC using a 2.1 mm  30 mm POROS pepsin column (Life 
Technologies/Applied Biosystems, Carlsbad, CA). After passing into the 0 ºC HDX 
chamber, the eluent becomes trapped on a BEH C18, 1.7 m, 2.1  5 mm guard column. 
For desalting and peptide separation, a 20 min water/acetonitrile (0.1% formic acid) 
gradient through a reverse-phase BEH 1.7 m, 1  100 mm C18 column was employed. The 
instrument parameters were set as follows: cone voltage 20 V, electrospray voltage 3 kV, 
source temperature 80 ºC and desolvation temperature 250 ºC.  
 
MSE data processing and peptide identification were preformed through Waters PLGS 
2.4.3. Peptide matches were manually vetted to ensure accuracy before employing Waters 
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DynamX 3.0 for analysis of HDX profiles. All experiments were performed in triplicates 
but due to the nature of some oxidized samples, a few time points were poorly matched by 
DynamX and deemed extraneous. Error bars are representative of the standard deviation 
between replicates. 
 
2.2.8 Collision Induced Unfolding - IMS 
Experiments were performed on a Synapt G2-Si ESI quadrupole-time-of-flight instrument 
set to sensitivity mode. The instrument parameters were set as follows: cone voltage 5 V, 
electrospray voltage 2.8 kV, source temperature 25 ºC and desolvation temperature 40 ºC. 
10 M protein samples were prepared in pH 7.4, 10 mM ammonium acetate, and infused 
directly by a syringe pump, flowing at 5 L/min. IMS was performed in N2 buffer gas with 
corresponding wave velocity of 350 m s-1 and wave height of 13 V. CCS values were 
calibrated using a mix of denatured and collisionally activated proteins in 49:49:2 (v/v/v) 
methanol/water/acetic acid.28 CCS were recorded for the native 9+ protein ion. Collision 
energy (using argon gas) was incrementally increased stepwise beginning at 0 V, 
proceeding through default instrument settings of 4 V trap and transfer and increasing 
steadily inside of a resolvable IMS range. 
2.2.9 Collision Induced Dissociation 
Experiments were performed on a Synapt G2-Si ESI quadrupole-time-of-flight instrument 
set to sensitivity mode. The instrument parameters were set as follows: cone voltage 5 V, 
electrospray voltage 2.8 kV, source temperature 25 ºC and desolvation temperature 40 ºC. 
10 M protein samples were prepared in pH 7.4, 10 mM ammonium acetate, and infused 
directly by way of a syringe pump, flowing at 5 L/min. Native 9+ protein ions were 
quadrupole-selected and subjected to incrementally increasing collisional energy inside the 
trap cell. Transfer collision energy was held constant at 4 V for every measurement outside 
of the initial step where all collision energy was turned to 0 V.  
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2.3 Results and Discussion 
2.3.1 Oxidation of Myoglobin 
Fenton chemistry is a common in vivo and in vitro oxidation mechanism, where iron ions 
catalyze the formation of highly reactive oxygen-based radicals from peroxides (Schemes 
1, 2).3,6,9,10,23 In heme-containing proteins such as myoglobin, hemoglobin, and cytochrome 
c, iron from the porphyrin ring can catalyze these processes.29–38  
The initial goal of this work was to create a workflow that would generate Mb oxidation 
products that would be relatively simple to characterize. Our primary aim was to attain full 
conversion to oxidized species, and secondly, minimize side reactions such that relatively 
homogeneous oxidation products would be obtained. Hydrogen peroxide (H2O2) is a well-
established oxidizing reagent; however, the high second order rate constant causes very 
low selectivity, increasing the complexity of the resultant products.23,39–43 Hence, after 
acquiring some preliminary data (not shown) we abandoned the use of H2O2 for the current 
work. Next, we tested chloramine-T as an oxidizing agent. However, problems were 
encountered with this reactant as well; we could not attain full conversion to oxidized 
protein without incurring overoxidation and numerous different peaks (data not shown). 
Ultimately, we settled on TBHP. This oxidant proved most effective in reproducible Mb 
oxidation, achieving a high level of conversion while avoiding overoxidation. TBHP 
oxidation of Mb resulted in mass distributions that were dominated by one prominent peak 
(Figure 2B, Peak 2) with two lower-abundance subspecies (annotated as Peaks 1 and 3 in 
Figure 2B). The notations “Peak 1”, “Peak 2”, and “Peak 3” will be used throughout the 
text to identify which species is being referenced. Without proper scrutiny, it would appear 
that oxidation with TBHP did not achieve full conversion, as a seemingly unoxidized 
fraction remained in the spectrum (Peak 1). However, closer inspection and isotopic 
modelling showed that Peak 1 is actually shifted -2 Da relative to the unmodified protein. 
Fine isotopic structure overlap comparing Peak 1 to unoxidized control myoglobin (Figure 
2C) accentuates the difference between the two species. 
A -2 Da mass shift could be the result of disulfide bond formation, carbonylation 
of alcohols, dityrosine formation, or a combination of two -1 Da lysine carbonylation 
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events.9,39,42–44 All of these outcomes were initially considered; however, since equine 
skeletal myoglobin contains no cysteine, disulfide bond formation is impossible. Similarly, 
the presence of only a single tyrosine (Y103) precludes the formation of dityrosine.45  
Peak 2 was shifted +14 Da relative to control. Although unlikely by Fenton-based 
TBHP oxidation,9,39 +14 Da modifications could result from aliphatic carbonylation at 
leucine, alanine and valine residues, or oxidation of tryptophan to oxolactone.46 
Considering the low likelihood of +14 Da covalent modification, it is more probable that 
Peak 2 is composed of the modifications causing the -2 Da shift in Peak 1 and a more 
common +16 Da modification (e.g., at methionine, tyrosine, or tryptophan). Peak 3 is the 
culmination of further +16 Da and -1 Da modifications, relative to Peak 2. Peak 3 and 
additional peaks are too low abundance and too broad for accurate characterization at this 
time, so the main focus of this work remained on Peaks 1 and 2. 
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Figure 2: A) Mass spectrum of unmodified Mb, with overlaid isotopic model, CS 25+. B) 
Mass spectrum of TBHP-oxidized Mb. The spectrum shows three main peaks (1, 2, 3), 
dominated by a +14 Da species (Peak 2). Peak 1 corresponds to a -2 Da shift. C) Overlay 
of isotopic structure of unoxidized (control) Mb, and Peak 1 of oxidized Mb. 
The occurrence of Fenton chemistry under the conditions used here implies that reactive 
radicals will be created adjacent to the heme group. For this reason, residues close to heme 
are most likely to experience covalent modification. The most probable amino acids to be 
oxidized based on proximity to heme and propensity of oxidation are highlighted in Figure 
3.9 These include Tyr103, and Lys96. Other residues non-proximal to heme that readily 
oxidize are also highlighted.9 These residues are Lys 56, Lys 102, Met55, Met131, Trp7, 
and Trp14.  
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Even without a detailed analysis of oxidation sites, the mass distributions seen in Figure 2, 
contain at least three reaction products, clearly highlighting the fact that Mb oxidation by 
TBHP is not a simple process that only affects Met residues (Mb possesses two Met in 
positions M55 and M131). The unexpected complex oxidation pattern seen here is in stark 
contrast to the findings of references 24 and 25, which painted a much simpler picture. 
Additional complexities became apparent when analyzing the mass distributions of the 
oxidized protein under denaturing ESI conditions. Traditional ESI-MS analyses commonly 
assume that all charge states under these conditions represent the same mass distribution.47 
Surprisingly, the samples studied here show a very different behavior. To assess the sample 
variability over different charge states, Figure 4A overlays all charge states in the ESI 
spectrum of TBHP-oxidized Mb. For higher charge states, the abundance of Peaks 1 and 3 
Figure 3: X-Ray crystal structure of Mb (pdb code 1wla). Residues in close proximity to 
heme that are likely to be oxidized. The zoomed in panel on the right highlights the 
proximity of heme to K96 and Y103, as well as proximity of Y103 to peptide 30-40. Colours 
are used to indicate sites of interest. Yellow: potential sites of -1 Da Lys oxidation. Red: 
site of +16 Da Tyr-oxidation. Blue: other residues of various interests i.e., potential 
oxidation targets (pictured left), spatial proximity to oxidized sites (pictured right). 
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is increased relative to Peak 2. Furthermore, low charge states appear shifted to the left, 
indicating the possibility of additional oxidative modifications. Figure 4B averages all the 
spectra derived from the individual charge states and produces an overall distribution that 
still shows Peak 2 as the most abundant signal with a mass increase of roughly +14 Da. 
Lower charge states show increasing extent of lysine oxidation (-1 Da) and therefore appear 
slightly left shifted. The higher charge states show very similar, overlapped mass profiles. 
The intensity of Peak 2 begins to decrease relative to Peaks 2 and 3, as charge state 
decreases. 
 
 
2.3.2 Characterization of Oxidative Modifications by Bottom-Up 
MS 
Being the gold standard of bottom-up proteomics, trypsin digestion is often the first step in 
identifying covalent modifications. Both the control (Figure 5A) and oxidized (Figure 5B) 
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Figure 4:  A) Deconvoluted mass distributions of various Mb charge states plotted on a 
mass axis. B) Average mass distribution generated by summing the data from panel A. 
Peak 1 averages to a roughly -2 Da shift, and Peak 2 averages to about +14 Da, relative 
to the unmodified control.  
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were digested under identical conditions but produced different LC chromatograms. 
Trypsin selectively cleaves after arginine and lysine due to their positive charge; if these 
sites become modified and lose their intrinsic charge, the enzyme will not cleave.48 Figure 
5 highlights the significant depletion of two peptides, 97-102 and 103-118, and minor 
depletion of 51-56, suggesting covalent modification of lysines K56, K96 and K102. This 
assay was unable to confirm the presence of lysine modifications as the corresponding 
missed-cleaved peptides were not apparent. Due to peak broadening in the oxidized 
chromatogram, data analysis software PLGS (Waters) and PEAKS (BSI) returned many 
false-positives and inaccurate sequence coverage. This prompted us to perform manual 
analyses of all the spectra. The emergence of a new chromatographic peak raised the 
possibility of incomplete digestion due to protein aggregation and/or crosslinked products 
as the MS and MS/MS data did not match any known or modified Mb peptide, even when 
using de novo workflows. We found no modification at either methionine (M55 and 
M131), thereby debunking previous claims by Imiołek et al. (see their Figure S8c)25 
regarding the purported selectivity of TBHP toward methionine under the exact conditions 
used in this experiment. Similarly, Keck24 had claimed that TBHP would specifically 
oxidize surface methionine residues although that author did not use Mb for his study. Our 
results did not uncover any +14 Da or +16 Da modified peptides, even with ~95% coverage 
of the oxidize protein. This suggests that the main modifications comprising Peak 2 must 
be located within the residues that were not covered in our experiments (97-102) or the 
peptides that were significantly depleted (51-56, 97-102, 103-118). 
Alternative proteases including Glu-C and chymotrypsin were also used in an attempt to 
further characterize oxidized Mb samples but resulted in far worse coverage and no 
additional information relative to trypsin alone. 
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Figure 5: A) LC/MS total ion chromatogram of a Mb tryptic digest (unmodified control), 
displaying complete digestion and 100% coverage. B) LC/MS total ion chromatogram of 
a Mb digest after oxidizing the protein with TBHP. Note the reduced digestion efficiency. 
Tryptic peptides 97-102 and 103-118 show significant depletion after oxidation - 
indicating oxidative modifications in those regions. C) Tryptic peptide coverage map. 
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2.3.3 Covalent Labelling of Oxidized Mb with GRT  
To test the possibility of lysine carbonylation to aminoadipic semialdehyde, covalent 
labelling with Girard’s reagent T (GRT) was used. GRT labelling forms products with a 
distinct mass shift of +116 Da (after reduction of the imine double bond).26,27,49,50 Figure 
6A shows the absence of GRT labels on unoxidized control Mb, after sufficient exposure. 
Figure 6B shows the TBHP-oxidized Mb sample prior to any GRT exposure. Figure 6C 
confirms the presence of carbonylated species present in Peaks 2 and 3, as resultant GRT-
tagged species appear +116 Da downstream once oxidized Mb is sufficiently exposed to 
GRT. The GRT tagged peaks that resulted from Peak 1 covalent labelling unfortunately 
became shadowed by the heightened baseline. Peaks 1 and 2 appeared significantly 
depleted and shifted by +2 Da, confirming that most of the species composing these peaks 
were lysine carbonylated. This pattern also reaffirms our initial suspicion that Peak 2 
comprises a +16 Da oxidation instead of a genuine +14 Da modification. 
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Figure 6: Mass spectra of Mb, CS 23+, after labeling with Girard’s reagent T (GRT). A) 
Control Mb only shows signals corresponding to the unmodified protein. B) TBHP oxidized 
Mb, before GRT exposure. C) Mb after exposure to GRT and bond reduction. Two new 
species are present in panel C, arising from the presence of a carbonyl group after TBHP 
exposure by the addition of a GRT group (+114 Da GRT, +2 Da bond reduction). Peaks 1 
and 2, previously -2 Da and +14 Da respectively relative to control have both shifted +2 
Da to the right, indicating the tagging of oxidized Lys by GRT.  
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2.3.4 Characterization of Oxidized Mb by Top-Down CID-IM/MS 
When proteolytic activity is compromised, as is the case for the scenario encountered here, 
the efficiency of bottom-up methods is limited. By combining bottom-up and top-down 
workflows and datasets, better characterization and even residue level resolution can be 
ascertained. Top-down CID-IM/MS goes beyond conventional MS/MS workflows by 
using ion mobility to separate fragments created by CID, adding another dimension of 
analysis and increasing effective resolution. Both control and oxidized myoglobin (Peak 2) 
samples were analyzed by CID-IM/MS and the resultant fragments were isotopically 
modelled (Figure 7). Direct comparison of b and y fragment ions originating from 
unmodified Mb and from the oxidized protein then reveals mass shifts that are diagnostic 
of specific covalent modifications. 
The first key finding from the data set were multiple unmodified fragments: y28-25, y23 
and y22. This observation confirms the previously established finding (chapter 2.3.2) that 
M131 shows no oxidation and is not the primarily oxidized residue in Peak 2. The second 
major finding was the region of overlap encompassing fragments: b68, 69, 71 and y83-81. 
Each of the b ions show only a -1 Da shift relative to control while each of the y ions in 
this segment show a +15 Da overall shift. This finding localizes a single lysine oxidation 
between residues V10 and V68. Although prior depletion of the tryptic peptide 51-56 
alludes to oxidation at lysine 56, without further assessment, the specific residue cannot be 
concluded. The +15 Da shift on the latter end of the protein indicates presence of both a 
+16 Da oxidation and a -1 Da oxidation.  
Initially, the top-down CID-IMS experiments only localized modifications between 
residues G73 – I112. However, after repeating these experiments with GRT-labelled 
oxidized protein, the emergence of an unmodified y51 ion permitted localization of 
additional modifications. By covalently binding lysine and possessing an intrinsic charge, 
GRT changes both the dissociation energy and pathway, leading to increased fragmentation 
in the region proximal to the tag.51 Prior bottom-up MS experiments concluded that K102, 
K96 and K56 were suspected of -1 Da oxidation, while a +16 Da modification occurred at 
a site between residues 97-118. Combining all available information from bottom-up and 
top-down, the lysine oxidation is most likely to be occurring at K102, supported by the 
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induced fragmentation pattern by GRT, and observed tryptic peptide drop-out. 
Furthermore, the +16 Da modification is localized to residues 96-103, of which Y103 lies 
closest to heme and has the highest propensity of oxidation via the TBHP MCO. 
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Figure 7: A) Precursor ion selection of control and oxidized Mb, both CS 25+. B) A series 
of modelled top down fragments obtained by CID-IM-MS. C) Resultant fragment map, 
annotated over the Mb sequence. 
 
2.3.5 Analysis of Protein Dynamics by HDX-MS 
After characterization and localization of TBHP-induced oxidative modifications in Mb, 
our focus shifted to protein dynamics in order to achieve a better understanding of how 
oxidative damage affects the protein behavior. 
As outlined earlier, HDX-MS of oxidized proteins presents a level of complexity that 
makes this type of experiment difficult, resulting in a scarcity of previous studies on this 
topic in literature. For addressing these difficulties, the current work involved extra steps 
to ensure proper characterization of covalent modification and also minimize variability of 
the sample (i.e., reproducibly achieve complete oxidation while avoiding overoxidation). 
HDX-MS software results for oxidized protein were manually scrutinized to assure 
accuracy of identified fragments and chemical shifts. Protease inhibition by oxidative 
modification again prevented analysis of oxidized peptides. To attain comprehensive 
coverage in regions where covalent modifications were previously identified, traces of 
residual unmodified peptides were used after rigorous vetting.  
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Figure 8: HDX kinetics of Mb peptic peptides, for unmodified control samples (green) and 
after TBHP oxidation (red). All points and error bars are derived from 3 replicates. 
Peptides marked with an asterisk (*) have 2 replicates for oxidized Mb. 
Figure 8 highlights the dynamic differences induced by oxidative stress. All peptides 
analyzed from an oxidized protein sample showed a higher deuterium uptake relative to 
the control counterpart. In other words, our data indicates enhanced structural dynamics 
throughout the protein after oxidation as new intra and intermolecular interactions form as 
a result of modified side chains. Covalent modifications may also interrupt or destabilize 
certain intramolecular interactions, producing more labile regions. Regions spatially 
adjacent to oxidative modifications exhibited the most pronounced uptake differences, 
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visible by the deep red colour projected onto the protein structure in Figure 9. The most 
affected regions correspond to peptides 30-40 and 87-103/106 (the 87-106 peptide was 
only present in the control sample, so the 87-103 peptide is substituted for the modified 
sample). Peptides 30-40 and 30-55 lie directly below K102 and Y103, two proposed sites 
of oxidation. The large increase in uptake of this region can be attributed to the presence 
of modified residues. Similarly, peptide 87-103 contains oxidized residues K102 and Y103, 
possibly inducing partial unfolding, resultant in the high deuterium uptake in this region. 
Containing the proximal His93, if this peptide is destabilized by the presence of oxidative 
damage, binding and interaction with heme may be adversely affected. Covalent 
modifications may also be altering adjacent peptide 70-86, as this region possesses a 
notable difference between extent of deuteration in control and modified samples. 
 
2.3.6 Oxidation Effects on the Behavior of Electrosprayed Mb Ions 
in the Gas Phase 
Under gentle experimental conditions, (e.g., temperature, solvent, pH, collision energy) 
electrosprayed proteins in the gas phase can maintain solution-like, non-denatured 
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Mb 
Oxidized 
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0% 100% 
Figure 9: Graphic representation of HDX kinetics (from Figure 8). 
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conformation. In the native state, a protein is fully folded and functional. Upon oxidation, 
the protein loses its native status, as these modifications may promote unfolding or disrupt 
intramolecular interactions. Therefore, analysis of gaseous protein ions in this context can 
divulge critical information about the detriment of oxidative stress on conformational 
dynamics.  
The first stage of gas-phase protein analysis involved the assessing the influence of 
oxidative damage on folding of the protein using IM-MS (Figure 10). The CCS was 
measured for the native 9+ charge state of control Mb, as well as Peaks 1, 2, and 3 of 
oxidized Mb. The first measurement was performed under very gentle conditions (i.e., no 
collision energy) to obtain a baseline reading. The collision energy was then gradually 
increased to assess how the different protein species begin to dynamically unfold in 
reaction as a result of higher energy collision with background gas. Since covalent 
modification can alter steric and electrostatic interactions, protein structure can either be 
destabilized and easily unfold or adopt new, more stable conformations instead. Control 
and oxidized species behave relatively similarly until 15 V of trap collision energy, where 
all peaks started to shift to a more unfolded state. 17.5 V appears to be a transition point 
for the control protein, as it adopts two major conformations – both partially shared with 
all three oxidized species. At 20 V trap collision energy, the control protein begins a major 
transition to a largely unfolded state – not shared by Peak 1 and 3 of oxidized protein and 
only partially shared by Peak 2. As energy continues to increase, no large changes are 
observed in Peaks 1 and 3; however, the control has mainly adopted the state with higher 
CCS. Peak 2 shares most conformation with Peak 1 and 3, maintaining a small subspecies 
that echoes that of the control. These findings suggest that the induction of oxidative stress 
on Mb affects its ability to unfold under native conditions, potentially limiting the dynamic 
freedom in some domains of the protein. 
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Under gentle ESI conditions, unmodified control myoglobin remained bound to its heme 
prosthetic group (Figure 11A). A different behavior is seen after TBHP exposure. Figure 
11D reveals that upon oxidation, the oxidized protein contains a relatively large fraction of 
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Figure 10: Unmodified control and oxidized Mb (Peaks 1, 2, 3) were collisionally activated 
by raising the trap collision energy, and changes in CCS were evaluated by IM-MS. The 
energy increase caused gradual unfolding of the holo-protein.  
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apoMb. This data implies that oxidation events destabilize the protein structure and disrupt 
coordination of the heme. ApoMb has a higher propensity to unfold than holoMb, and does 
not retain function. 
 
Figure 11: ESI mass spectra of oxidized (red) and control (green) Mb acquired under non-
denaturing conditions. (A, D): Full mass spectra. (B, E): Close-up views of the hMb9+ 
signals. (C, F) hMb9+ signals after precursor selection. The selected ions in panels C and 
F were then interrogated by collision-induced dissociation (see subsequent figures). 
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To further assess the properties of the holo protein, the native 9+ control and Peaks 1, 2, 
and 3 were selectively subjected to increasing amounts of trap collision energy, inducing 
dissociation of heme in the gas phase. Figure 12 illustrates this process for control Mb, 
showing data for only three of the seven collision energy values. This experiment probes 
the stability of the protein in the gas phase and alludes to its overall stability by measuring 
propensity to retain heme. On a discontinuous axis (heme on left, m/z 616), Figure 12 
shows spectra monitoring the production of free heme+ and subsequent apoMb species.  
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Figure 12: Collision-induced dissociation of hMb9+, resulting in the formation of heme+ 
and apoMb8+. A small fraction of the heme leaves as neutral, generating apoMb9+ 
product ions. The data shown here illustrate the behavior of an unoxidized control protein 
sample.                  
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Figure 13: Collision induced dissociation of hMb9+ ions into heme+ and apoMb8+ the gas 
phase, unmodified control and after TBHP oxidation (Peaks 1,2,3). Relative percentage of 
overall signal of heme+ (top plot), holo9+ (middle plot), apo8+ (bottom plot) are plotted as 
a function of collision energy.  
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Figure 13 graphically summarizes the spectral analysis of the experiment depicted in 
Figure 12 - interrogation of the main peaks: heme, hMb9+ and apoMb8+. These graphs show 
the change in proportion of overall signal for heme, hMb9+, and apoMb8+ as collision 
energy increases. Peaks 1 and 3 start losing their heme already at relatively low levels of 
activation, while control Mb lags behind, releasing heme less readily than the oxidized 
counterparts. As the collision energy increases, Peaks 1 and 3 most readily deplete the holo 
9+ protein, producing apo 8+. Control Mb; however, shows stability through lower 
collisional energies and resists the transition until higher energy (50 V) where it rapidly 
converts from holo 9+ to apo 8+. Control Mb exhibits the lowest propensity to release 
heme, maintaining higher levels hMb instead of early conversion to apoMb like Peaks 1 
and 3. These results show that unoxidized Mb exhibits the greatest gas phase stability, 
while oxidized protein species release heme readily even at low collision energy. These 
data suggest that the interrogation of gaseous protein ions can yield structural and stability 
information that is relevant to the behavior of proteins in solution – thereby expanding the 
MS toolbox. 
2.4 Conclusions 
MS provides many different methods for analysis of oxidative modification of protein. 
Alone, each individual method may be insufficient, but upon combining information from 
the various approaches, a comprehensive picture can be obtained. This data is required for 
characterizing covalent modifications and assessing their impact on protein structure and 
dynamics. In the context of myoglobin oxidation, TBHP proved to be an effective agent 
for obtaining fully oxidized samples. Unlike the previous studies by Imiołek et al.,25 and 
Keck24 however, our results clearly demonstrate that TBHP is by no means methionine 
specific. One main oxidized species dominates while possessing two prominent 
subsidiaries. Often overlooked in prior works, lysine carbonylation to aminoadipic 
semialdehyde exists in each of the oxidized species, primarily at K102. The current work 
was unable to specifically localize the second lysine oxidation with a high degree of 
confidence; however, it provides a narrow range of possible residues. Careful examination 
of multiple data sets revealed that Y103 is the predominant site of +16 Da oxidation, 
contributing to the main oxidized species (Peak 2). HDX-MS required strenuous sample 
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and procedural optimization but provided valuable insight to oxidized protein dynamics. 
Regions spatially adjacent to sites of oxidative modification exhibited higher deuterium 
uptake, correlating with high mobility and regional unfolding. The high lability of the 87-
103 peptide indicates possible disruption of the His93-heme coordination. Oxidized Mb 
exhibits higher propensity to unfold and lose its heme, although IMS data show that it 
adopts a more compact activated structure, relative to its control counterpart. The 
combination of reproducible oxidation and various MS analysis methods used provides a 
comprehensive workflow for analyzing effects of oxidative stress on proteins, also 
highlighting areas of analysis that require closer attention. 
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3 Conclusions and Future Work 
 
3.1 Conclusions 
An aging population accentuates the importance of understanding pathology of common 
ailments. Oxidative damage is a leading cause of cellular disfunction leading to age-related 
disease.1–10 This project employed TBHP to oxidize the model protein, myoglobin, to 
mimic events of protein oxidative damage, in vitro. The work in this thesis explores 
complementary MS methods that can be used to characterize covalent modification by 
inducing oxidative damage and assesses the ensuing effect on the dynamics of the protein. 
The study highlights the insufficiencies and common obstacles of traditional bottom-up 
characterization methods when working with oxidized protein. Inhibition of proteolytic 
cleavage and an abundance of false positive hits by proteomics software are two of the 
main factors that plague bottom-up analysis of oxidized proteins. Experimental design 
should acknowledge these difficulties accordingly before experimenting further or 
concluding final results. Top-down analyses are less hindered by protein oxidation, 
providing a more robust avenue for the identification of covalent modifications. The 
combination of information provided by bottom-up and top-down MS helps achieve 
residue-level resolution far better than by each method on its own. With that, covalent 
modifications can be confidently identified and localized before proceeding to analyze 
protein dynamics. 
To comprehensively describe the effects of oxidative damage on protein dynamics, this 
work applies a variety of methods including IMS, collision-induced activation (unfolding), 
collision induced dissociation (CID) and HDX-MS. HDX-MS has long been revered in 
protein dynamic analysis but the significant lack of literature surrounding oxidized proteins 
highlights the existing challenges of this methodology. HDX-MS experimentation on 
oxidized proteins holds the potential to disseminate intricate impacts on protein dynamics 
that lead to protein aggregation and loss of function. This work addresses complications 
attributed to sample complexity and accurate peptide mapping to draw conclusions 
surrounding the dynamic behavior of oxidized protein.  
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This work is intended to highlight the capability of MS in analyzing oxidized protein and 
assessing oxidative damage. Oxidative damage plays a central role in various disease 
mechanisms, such that understanding which workflows will produce accurate and reliable 
results is imperative. Future work can apply the methods used in this project to successfully 
study proteins of pathological interest related to common ailments. Myoglobin served as a 
model protein for the current study, but a similar experimental design can be applied to any 
protein of interest with minor customizations. Gradually increasing the extent of oxidation 
on protein systems may also uncover aggregation mechanisms and tendencies. As MS 
continues to evolve, the series of techniques used in this project will continue to provide a 
comprehensive suite of information. 
3.2 Future Work 
Lysine oxidation to aminoadipic semialdehyde remains a commonly overlooked covalent 
modification due to miniscule m/z differences relative to control samples. Characterization 
of these modifications requires instruments with high resolving power and a trained eye. 
Development of more robust characterization workflows would help better identify these 
modifications and the interactions they cause. One of the lysine modifications on 
myoglobin was localized to a small region of amino acids, but we were not able to pinpoint 
the exact residue even after the application of multiple proteases and top-down workflows. 
Future work should assess and utilize the effectiveness of covalent labelling with fixed-
charge molecules on promotion of better fragmentation in top-down MS.11 
Currently, no software suite is available to assist in processing results from CID-IM-MS, 
resulting in very tedious data analysis; however, manual analysis provides thorough, high-
confidence conclusions. Time investment could be largely optimized by development of 
software suites to assist users with targeted spectral assessment; however too much reliance 
on software to accurately analyze complex protein systems can oversimplify results.  
Software results must always be rationalized and verified by users to avoid missing 
pertinent data and drawing misled conclusions, as proven in this work. 
HDX-MS was successfully applied to probe the altered dynamics of an oxidized protein 
system in this work. Future studies are aimed at obtaining better peptide coverage, 
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specifically in regions containing covalent modifications. With coverage of oxidized 
peptides, the effect of oxidized residues can be probed on neighboring amino acids. This 
would provide further insight into oxidative damage dynamics which is currently 
unobtainable due to deficiencies in bottom-up workflows. Mixed protease columns may be 
considered for future use. Further, with this work demonstrating the merit of HDX-MS on 
oxidized proteins, more heavily oxidized protein systems with pathological relevance 
should be assessed by the same metrics. 
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